Chi-yuan Hsu

MD MS FACP

Chief, Division of Nephrology
Nephrologist

Dr. Chi-yuan Hsu is a specialist in kidney disease. He cares for adults who are hospitalized as well as those visiting the clinic. He is chief of the UCSF Division of Nephrology.

Hsu's research on acute, chronic and end-stage kidney disease includes investigating strategies to improve outcomes for patients with these conditions. Questions that arise in the course of caring for patients have often motivated his research.

Hsu earned his medical degree from Harvard Medical School and a master's degree in clinical epidemiology from the Harvard T.H. Chan School of Public Health. He completed a residency in internal medicine at Beth Israel Deaconess Medical Center, followed by a fellowship in nephrology at Massachusetts General Hospital.

Hsu is a member of the American Society for Clinical Investigation, American Medical Association, American College of Physicians, National Kidney Foundation, International Society of Nephrology, Chinese American Society of Nephrology, Association of Specialty Professors and Renal Physicians Association. He is a fellow of the American College of Physicians and American Society of Nephrology, and has been voted a best doctor by San Francisco magazine, Marin Magazine and Castle Connolly, a consumer guide to preeminent U.S. health care.

  • Education

    Harvard Medical School, 1993

    Harvard School of Public Health, MS, Clinical Epidemiology, 1999

  • Residencies

    Beth Israel Deaconess Medical Center, Internal Medicine, 1996

  • Fellowships

    Massachusetts General Hospital, Nephrology, 1998

  • Board Certifications

    Nephrology, American Board of Internal Medicine

  • Academic Title

    Professor

  • Languages

    Cantonese

    Mandarin

I strive to conduct research that is highly pertinent to patient care. Many of my ideas start from seeing patients and realizing gaps in our knowledge.

Conditions I specialize in

Where I see patients (1)

    Selected research

    See all research
    Decorative Caduceus

    The Home Blood Pressure (BP) Trial

    Test the effect of treating home SBP <140mmHg vs a pre-dialysis SBP <140mmHg on rates of IDH

    Recruiting

    Decorative Caduceus

    APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

    Time from receipt of kidney transplant to death-censored renal allograft failure. Measured in days.

    Recruiting

    Decorative Caduceus

    Liberation From Acute Dialysis

    Alive and off dialysis at the time of discharge, with sustained independence from dialysis for 14 days. This outcome does not require that all 14 days of sustained independence occur in-hospital.

    Recruiting

    Contact me

    Share